[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350444-105":59,"doc-detail-350444-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-diagnostic-signature-derived-from-nk-cell-related-genes-in-prostate-cancer-insights-from-integrated-scrna-seq-and-bulk-rna-seq-analyses-with-functional-validation-of-kit","A diagnostic signature derived from NK cell related genes in prostate cancer - insights from integrated scRNA-seq and bulk RNA-seq analyses - with functional validation of KIT","","A diagnostic signature derived from NK cell-related genes is developed for prostate cancer by integrating single-cell and bulk transcriptomic evidence. Natural killer (NK) cell dysfunction, linked to immune evasion, motivates the study to construct robust diagnostic biomarkers. Using scRNA-seq-driven NK gene discovery, weighted co-expression network analysis, LASSO regression, and machine learning, nine genes are combined into a predictive model validated across independent datasets. Functional assays emphasize KIT as a candidate, demonstrating increased NK-92 cytotoxicity and tumor suppression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-diagnostic-signature-derived-from-nk-cell-related-genes-in-prostate-cancer-insights-from-integrated-scrna-seq-and-bulk-rna-seq-analyses-with-functional-validation-of-kit/350444/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-diagnostic-signature-derived-from-nk-cell-related-genes-in-prostate-cancer-insights-from-integrated-scrna-seq-and-bulk-rna-seq-analyses-with-functional-validation-of-kit/350444.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To develop a robust diagnostic signature based on NK cell-related genes for prostate cancer and validate its predictive performance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the diagnostic model constructed and validated?",{"text":117,"@type":113},"NK-related genes were identified from scRNA-seq and then used with weighted gene co-expression network analysis, LASSO regression, and machine learning to build a diagnostic model. Gene expression was validated in tumor and adjacent normal tissues and further confirmed in independent datasets.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional role did KIT show in prostate cancer?",{"text":121,"@type":113},"KIT overexpression enhanced NK-92 cytotoxicity against PC-3 cells, inhibited cancer cell viability, migration, and invasion, and increased cytokine secretion and degranulation marker CD107a.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350444,1790194498,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 03 June 2026  \nDOI 10.3389/fimmu.2026.1692792  \nOPEN ACCESS  \nEDITED BY  \nRosa Molfetta,  \nSapienza University of Rome, Italy  \nREVIEWED BY  \nJun Pang,  \nSun Yat-sen University, China Maria Teresa Palano, MultiMedica (IRCCS), Italy  \n*CORRESPONDENCE  \nShida Fan  \n[18728593998@163.com](18728593998@163.com)[ ](18728593998@163.com)Dong Wang  \n[wangdong_robot@163.com](wangdong_robot@163.com)[ ](wangdong_robot@163.com)†These authors have contributed equally to this work and share the ﬁrst authorship  \nRECEIVED 26 August 2025  \nREVISED 15 May 2026  \nACCEPTED 18 May 2026  \nPUBLISHED 03 June 2026  \nCITATION  \nChen Z, Zhou F, Tian J, Lv Q, Wang D and Fan S (2026) A diagnostic signature derived from NK cell related genes in prostate cancer: insights from integrated scRNA-seq and bulk RNA-seq analyses with functional validation of KIT.  \nFront. Immunol. 17:1692792 .  \ndoi: 10.3389/fimmu.2026.1692792  \nCOPYRIGHT  \n© 2026 Chen, Zhou, Tian, Lv, Wang and Fan. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nA diagnostic signature derived from NK cell related genes in prostate cancer: insights from integrated scRNA-seq and bulk RNA-seq analyses with functional validation of KIT  \nZhengjun Chen †, Fang Zhou †, Jingzhi Tian, Qian Lv, Dong Wang* and Shida Fan*  \nRobotic Minimally Invasive Surgery Center, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China  \nBackground: Prostate cancer is one of the most common malignant tumors of the male genitourinary system. The impaired activity of natural killer (NK) cells observed in prostate cancer may contribute to immune evasion. This study aimed to develop robust NK cell-related diagnostic signatures.  \nMethods: Based on NK related genes identiﬁed by scRNA-seq analysis, weighted gene co-expression network analysis, least absolute shrinkage and selection operator regression analysis, and machine learning algorithms were used to develop a novel diagnostic model. The expression of diagnostic genes was validated using tumor and adjacent normal tissues collected from prostate cancer patients. The biological functions of KIT as an NK cell related gene were further evaluated in prostate cancer cells.  \nResults: A nine-gene NK cell-related diagnostic signature was developed, including HSPD1, HSPE1, CLU, KIT, LAPTM4A, SLC18A2, TUBA4A, VWA5A, and ZFP36L1 . These genes were validated in independent datasets and showed strong predictive ability for prostate cancer diagnosis (AUC >0 . 8) . Based on the expression proﬁles of these genes, nine compounds were identiﬁed that may inﬂuence drug sensitivity in prostate cancer. Furthermore, the expressions of CLU, TUBA4A, and KIT were successfully validated in collected prostate cancer tissue samples. Functional experiments demonstrated that KIT overexpression enhanced the cytotoxicity of NK-92 cells against prostate cancer PC-3 cells, inhibited cancer cell viability, cell migration and invasion, and increased the secretion of cytokines such as IFN-g, Gzms-A, Gzms-B, and Perforin, as well asthe degranulation marker CD107a.  \nConclusion: This study provides a new understanding of NK cell related gene signatures in prostate cancer diagnosis and highlights KIT as a promising candidate for future therapeutic investigation. Further research is needed to explore the mechanisms underlying the expression of these genes and their roles in the tumor microenvironment.  \nKEYWORDS  \ndiagnostic model, immunotherapy, NK cell marker genes, prostate cancer, single-cell and bulk RNA-s","cbCaisNhivv4JP6I","https://ap.wps.com/l/cbCaisNhivv4JP6I","pdf",8766724,15,"English","# 1 Introduction\n# 2 Methods\n# 3 Results\n# 4 Conclusion","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To develop a robust diagnostic signature based on NK cell-related genes for prostate cancer and validate its predictive performance.\"},{\"question\":\"How was the diagnostic model constructed and validated?\",\"answer\":\"NK-related genes were identified from scRNA-seq and then used with weighted gene co-expression network analysis, LASSO regression, and machine learning to build a diagnostic model. Gene expression was validated in tumor and adjacent normal tissues and further confirmed in independent datasets.\"},{\"question\":\"What functional role did KIT show in prostate cancer?\",\"answer\":\"KIT overexpression enhanced NK-92 cytotoxicity against PC-3 cells, inhibited cancer cell viability, migration, and invasion, and increased cytokine secretion and degranulation marker CD107a.\"}]","A diagnostic signature derived from NK cell related genes in prostate cancer - insights from integrated scRNA-seq and bulk RNA-seq analyses - with functional validation of KIT | PDF",1790089064,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d29950706d63bacea31aa136185b8891.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4009459119ee0862a501f1dc744d026.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8664aeb38f9a7a94e28f8af18872fea5.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/475dc6546cd37da6ad67f3cf049925ba.webp",980,1385]